The deal will allow HippoFi to sell Pur Biologics products alongside Precision Spine’s implant portfolio, HippoFi said in an Oct. 5 news release. Pur Biologics is a division of HippoFi.
The partnership is expected to speed up the commercialization of the regenerative products through Precision Spine’s brand recognition.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
